PF-04840082

• Target:

  Wnt/beta-catenin

• Related Pathways:

  Cytoskeletal Signaling|||Stem Cells

• Bioactivity:

  PF-04840082 is a humanized IgG2 monoclonal antibody inhibitor targeting Dkk-1. It binds to the physiological antagonist (Dkk-1) of the Wnt/LRP5 signaling pathway, which enhances bone mass and density by activating osteoblasts. PF-04840082 is applicable for osteoporosis research.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C